Bioadaptives, Inc. (BDPT) Change in Accured Expenses (2014 - 2026)

Bioadaptives has reported Change in Accured Expenses for 12 years, with the latest figure at $16161.0 in Q1 2026.

• Quarterly Change in Accured Expenses rose 30.77% year-over-year to $16161.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $57070.0 (up 22.0% YoY) and the FY2025 annual result came in at $53267.0, up 18.82% from the prior year.
• Change in Accured Expenses grew to $16161.0 in Q1 2026 per BDPT's latest filing, from $1957.0 in the prior quarter.
• Over five years, Change in Accured Expenses peaked at $89608.0 in Q1 2022 and troughed at $1957.0 in Q4 2025.
• A 5-year average of $19864.4 and a median of $12265.0 in 2025 frame the typical range for Change in Accured Expenses.
• The sharpest annual moves came in 2022 and 2023: Change in Accured Expenses surged 652.39% in 2022, then slumped 93.82% in 2023.
• Over 5 years, Change in Accured Expenses stood at $11575.0 in 2022, then fell by 11.85% to $10203.0 in 2023, then decreased by 6.48% to $9542.0 in 2024, then plunged by 79.49% to $1957.0 in 2025, then soared by 725.8% to $16161.0 in 2026.
• According to Business Quant data, Change in Accured Expenses over the past three periods registered $16161.0, $1957.0, and $26687.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.